• Explore /
  • Poster
  • / MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma—Trial in Progress.

MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma—Trial in Progress.

Abstract Poster

Authors

John Strickler

John H. Strickler

Duke University Medical Center, Durham, NC

John H. Strickler , Yoshiaki Nakamura , Takayuki Yoshino , Daniel V.T. Catenacci , Yelena Y. Janjigian , Afsaneh Barzi , Tanios S. Bekaii-Saab , Heinz-Josef Lenz , Jeeyun Lee , Eric Van Cutsem , Hyun Cheol Chung , MARIA ALSINA , Salvatore Siena , Joal Garrido Mayor , Maria Corinna Palanca-Wessels , Wentao Feng , John Marshall

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session: Esophageal and Gastric Cancer

Track

Esophageal and Gastric Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04499924

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr TPS252)

DOI

10.1200/JCO.2021.39.3_suppl.TPS252

Abstract #

TPS252

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Daniel V.T. Catenacci

First Author: Tanios S. Bekaii-Saab

First Author: Tanios S. Bekaii-Saab

First Author: Haeseong Park